CGON
Common StockCG Oncology, Inc.
Reported Shares
1.1M
Position Mix
No options reported
Reported Value
$80.2M
Portfolio Weight
22.05%
Reported 13F portfolio for Q3 2026.
Reported 13F Portfolio Value
$363.8M
Data Refreshed
Nov 17, 2026
Portfolio Structure
Company profiles & logos by Twelve Data
CGON
Common StockCG Oncology, Inc.
Reported Shares
1.1M
Position Mix
No options reported
Reported Value
$80.2M
Portfolio Weight
22.05%
URGN
Common StockUroGen Pharma Ltd.
Reported Shares
1.6M
Position Mix
No options reported
Reported Value
$67.0M
Portfolio Weight
18.41%
PBYI
Common StockPUMA BIOTECHNOLOGY, INC.
Reported Shares
4.1M
Position Mix
No options reported
Reported Value
$41.0M
Portfolio Weight
11.28%
CADL
Common StockCandel Therapeutics, Inc.
Reported Shares
3.5M
Position Mix
No options reported
Reported Value
$36.5M
Portfolio Weight
10.04%
TRVI
Common StockTrevi Therapeutics, Inc.
Reported Shares
2.1M
Position Mix
No options reported
Reported Value
$30.7M
Portfolio Weight
8.44%
HELP
Common StockHelus Pharma Inc.
Reported Shares
1.5M
Position Mix
No options reported
Reported Value
$18.9M
Portfolio Weight
5.20%
JBIO
Common StockJade Biosciences, Inc.
Reported Shares
986.8K
Position Mix
No options reported
Reported Value
$13.9M
Portfolio Weight
3.81%
BCAX
Common StockBicara Therapeutics Inc.
Reported Shares
668.4K
Position Mix
No options reported
Reported Value
$12.4M
Portfolio Weight
3.42%
VSTM
Common StockVerastem, Inc.
Reported Shares
1.5M
Position Mix
No options reported
Reported Value
$11.8M
Portfolio Weight
3.25%
OKUR
Common StockOnKure Therapeutics, Inc.
Reported Shares
2.8M
Position Mix
No options reported
Reported Value
$7.8M
Portfolio Weight
2.13%
ENGN
Common StockenGene Therapeutics Inc.
Reported Shares
3.8M
Position Mix
No options reported
Reported Value
$7.6M
Portfolio Weight
2.10%
ANTX
Common StockAN2 Therapeutics, Inc.
Reported Shares
1.3M
Position Mix
No options reported
Reported Value
$6.9M
Portfolio Weight
1.90%
AURA
Common StockAura Biosciences, Inc.
Reported Shares
1M
Position Mix
No options reported
Reported Value
$6.4M
Portfolio Weight
1.77%
TARA
Common StockProtara Therapeutics, Inc.
Reported Shares
1.8M
Position Mix
No options reported
Reported Value
$5.3M
Portfolio Weight
1.47%
ANNX
Common StockAnnexon, Inc.
Reported Shares
1.1M
Position Mix
No options reported
Reported Value
$4.8M
Portfolio Weight
1.32%
LONA
Common StockLeonaBio, Inc.
Reported Shares
1.1M
Position Mix
No options reported
Reported Value
$4.1M
Portfolio Weight
1.12%
WHWK
Common StockWhitehawk Therapeutics, Inc.
Reported Shares
932.1K
Position Mix
No options reported
Reported Value
$3.5M
Portfolio Weight
0.96%
QTTB
Common StockQ32 Bio Inc.
Reported Shares
216.2K
Position Mix
No options reported
Reported Value
$1.8M
Portfolio Weight
0.49%
KPTI
Common StockKaryopharm Therapeutics Inc.
Reported Shares
1.2M
Position Mix
No options reported
Reported Value
$1.5M
Portfolio Weight
0.41%
JSPR
Common StockJasper Therapeutics, Inc.
Reported Shares
1.4M
Position Mix
No options reported
Reported Value
$834.1K
Portfolio Weight
0.23%